Benefit-risk assessment of orlistat in the treatment of obesity.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Works matching IS 01145916 AND DT 2014 AND VI 37 AND IP 8
Results: 10
1
2
Improved statistical signal detection in pharmacovigilance by combining multiple strength-of-evidence aspects in vigiRank.
- Published in:
- 2014
- By:
- Publication type:
- journal article
3
Undesirable effects related to oral antineoplastic drugs: comparison between patients' internet narratives and a national pharmacovigilance database.
- Published in:
- 2014
- By:
- Publication type:
- journal article
4
A comparison of active adverse event surveillance systems worldwide.
- Published in:
- 2014
- By:
- Publication type:
- journal article
5
Advancing the field of pharmaceutical risk minimization through application of implementation science best practices.
- Published in:
- 2014
- By:
- Publication type:
- journal article
6
Identification of suicide-related events through network analysis of adverse event reports.
- Published in:
- 2014
- By:
- Publication type:
- journal article
7
Comment on: "Pharmacovigilance in the Middle East".
- Published in:
- 2014
- By:
- Publication type:
- Letter
8
Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interest.
- Published in:
- 2014
- By:
- Publication type:
- journal article
9
Indicators of drug-seeking aberrant behaviours: the feasibility of use in observational post-marketing cohort studies for risk management.
- Published in:
- 2014
- By:
- Publication type:
- journal article
10
Erratum to: Association of Statin Use with Sleep Disturbances: Data Mining of a Spontaneous Reporting Database and a Prescription Database.
- Published in:
- Drug Safety, 2014, v. 37, n. 8, p. 653, doi. 10.1007/s40264-014-0200-9
- By:
- Publication type:
- Article